common side effects of minivelle
headache
other side effects
limb pain
comprehensive list of adverse effects
other dosage forms:
following symptoms of overdose
taking estradiol
emergency help
cases of oral pigmentation
ischemic colitis
gastrointestinal side effects
nausea
abdominal cramps
bloating
vomiting
studies
fold increase in gallbladder disease in postmenopausal women
taking estrogen therapy
cholestatic jaundice
pancreatitis
enlargement of hepatic hemangiomas
postmarketing experience with the vaginal ring
few cases of bowel obstruction
vaginal ring use
postmarketing
postmarketing side effects with vivelle-dot
nausea
vomiting
abdominal cramps
bloating
cholelithiasis
diarrhea
oncologic side effects
reports of an
increased risk of endometrial carcinoma in patients with an intact uterus
increased risk of breast cancer
number of studies
risk of endometrial carcinoma
administration of progestins in combination with estrogen therapy
increased risk of breast cancer
estrogens
several studies
long-term estrogen therapy
increased risk of breast cancer
meta analysis of studies
epidemiological data
modest risk increase
long-term hormone replacement therapy
hrt
study of swedish women
increase in the relative risk of breast cancer
risk
increasing duration of estrogen therapy
study
women with more
years of estrogen use
greater relative risk of breast cancer than controls
study
examined use of a variety of estrogen preparations of which estradiol
addition
women
progestins
decreased risk of breast cancer
higher risk
toronto breast cancer study
women
unopposed conjugated estrogens for less than years
increased risk of breast cancer
study
increase in the risk of breast cancer for women
conjugated estrogens for more than years
case-control surveillance study
evidence that the use of unopposed
unopposed conjugated estrogens
risk of breast cancer
long duration of use
long latent intervals
possibility of a modest increase
doubling
nurses
health study
increased risk of breast cancer in women
taking estrogen replacement therapy
risk
concurrent use of progestins
study
greater risk
advanced age
prolonged duration of hormonal therapy
study of middle-aged women in the puget sound area
whole
use of estrogen with progestin hrt
hormone replacement therapy
increased risk of breast cancer in middle-aged women
prospective cohort study
years
women by gapstur
histology of the breast cancer in women
hrt
association
duration
hrt use
incidence of ductal carcinoma
invasive ductal/lobular carcinoma
duration
hrt use
risk of invasive carcinoma with a favorable prognosis
relative risk
rr
confidence interval
ci
hrt
yrs
rr
ci
hrt
> yrs
p
relative risk of invasive carcinoma with a favorable prognosis for current users
age
other risk factors
ci
yrs
ci
> yrs
risk of invasive ductal
lobular carcinoma for current users
yrs
rr
ci
reported effects of estrogens on cardiovascular activity
alterations in lipid profiles in treated women
reducing
reducing cardiovascular risks
data
estrogen use
blood pressure
patients
receiving high doses
blood pressure
change
addition
noncontraceptive use of estrogens in young women
smokers
risk of nonfatal myocardial infarction
other studies
increased risk of myocardial infarction
cardiovascular
side effects
studies
unopposed estrogen therapy
risk of coronary heart disease
combination therapy with a progestin
decreased coronary risk
extent of risk reduction with combination therapy
data
combination therapy
overall rate of coronary heart disease in postmenopausal women with established coronary disease
postmarketing
postmarketing side effects with vivelle-dot
deep vein thrombosis
pulmonary embolism
thrombophlebitis
metabolic side effects
reports
favorable alterations in plasma lipid profiles
hdl
cholesterol
ldl levels
estrogen therapy
increased serum triglyceride levels
pancreatitis in patients with familial lipoprotein
metabolic defects
metabolic adverse effects
hypercalcemia
patients with breast cancer
bone metastases
endocrine side effects
increased levels of thyroxin-binding globulin
increased total thyroid serum levels
resin uptake of t
free thyroid hormone levels
other endocrine effects
decreased fasting plasma glucose
general
side effects
fluid retention
mastodynia
alterations in libido
postmarketing experience with the vaginal ring
few cases of toxic shock syndrome
postmarketing
postmarketing side effects with vivelle-dot
decrease in weight
carbohydrate tolerance
edema
hepatic side effects
reports of focal nodular hyperplasia
liver cell adenomas
hepatic hemangiomas
well-differentiated hepatocellular carcinomas
aggravation of porphyria
postmarketing
postmarketing side effects with vivelle-dot
abnormal liver function tests
reports of hepatic tumors
women
taking long-term oral contraceptives
tumors
women
taking isolated estrogen therapy
hematologic side effects
hypercoagulability
increase in venous thromboembolism
clinical significance of such hypercoagulability in postmenopausal women
taking estrogens
ocular side effects
alterations in corneal curvature
contact lens discomfort
retinal vascular thrombosis
postmarketing
postmarketing side effects with vivelle-dot
intolerance
lenses
hypersensitivity side effects
reports of reactions
anaphylaxis
reports
dyes
conjugated estrogen formulations
urticaria
angioedema
postmarketing reports
transdermal product
climara
few cases in which
combination of the symptoms
generalized hives
rash
swelling of the throat
eyelid edema
other side effects
reports of a possible increase in the risk
fibrocystic breast disease
postmarketing
postmarketing side effects with vivelle-dot
breast enlargement
pain
nipple discharge
fibrocystic breast changes
breast cancer
psychiatric side effects
case reports of rapid mood cycling in patients with severe depression
postmarketing
postmarketing side effects with vivelle-dot
nervousness
liability
irritability
nervous system
side effects
dementia
dizziness
mental depression
headache
nervousness
irritability exacerbation of epilepsy
new onset
exacerbation of migraine headaches
case of chorea
association with estrogen therapy
dermatologic side effects
chloasma
melasma
following discontinuation of estrogen therapy
scalp hair loss
hirsutism
erythema nodosum
hemorrhagic eruptions
postmarketing
postmarketing side effects with vivelle-dot
erythema multiforme
pruritus
purpura
rash
genitourinary side effects
abnormal uterine bleeding
dysmenorrhea
cases
bleeding
endometrial carcinoma
addition
estrogens
size
preexisting
preexisting uterine leiomyomata
postmarketing experience with the vaginal ring
few cases of ring adherence
vaginal wall
making removal
postmarketing
postmarketing side effects with vivelle-dot
vaginal hemorrhage
abnormal withdrawal bleeding
flow
breakthrough bleeding
spotting
uterine leiomyomata
vaginitis
vaginal discharge
ovarian cancer
endometrial hyperplasia
musculoskeletal side effects
arthralgias
postmarketing
postmarketing side effects with vivelle-dot
leg cramps
transdermal emulsion
transdermal patch
release
transdermal spray
vaginal yeast infection
change in vaginal discharge
bloody discharge from the nipple
decrease in the amount of urine
dimpling of the breast skin
fast heartbeat
fever
hives
itching
rash
hoarseness
inverted nipple
irritation
joint pain
stiffness
swelling
lump in the breast
arm
noisy, rattling breathing
pain
feeling of pressure in the pelvis
pain
redness
swelling in the arm
leg
scaling of the nipple
redness of the skin
redness
swelling of the breast
skin of the breast
swelling of the eyelids
face
fingers
lips
hands
feet
lower legs
tightness in the chest
troubled breathing at rest
troubled breathing
swallowing
vaginal bleeding
stomach pain
dizziness
drowsiness
nausea or vomiting
tenderness of the breasts
unusual tiredness
weakness
back pain
headache
itching
pain of the vagina
genital area
white vaginal discharge with mild
odor
weight gain
body aches
pain
chills
cough
diarrhea
ear congestion
loss of voice
nasal congestion
runny nose
sneezing
sore throat
feeling
headache
irritability
lack of appetite
tiredness
trouble concentrating
trouble sleeping
welts